Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

NCT01635959 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01635959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01635959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
July 31, 2014
Enrollment
3,170 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

patients with upper gastro-intestinal symptoms